Pharmacy Focus – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Pharmacy Focus

Pharmacy Times

Health & Fitness

Frequency: 1 episode/5d. Total Eps: 301

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy. Winner of the 2021 Digital Health Media/Publications Audio Merit Award.

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇨🇦 Canada - medicine
23/09/2024
#84
🇨🇦 Canada - medicine
11/09/2024
#89
🇨🇦 Canada - medicine
08/09/2024
#85
🇨🇦 Canada - medicine
07/09/2024
#53

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://s.surveyplanet.com/z5cp0c3r
10 shares
https://drjessicalouie.com/
4 shares
https://chat.openai.com/
3 shares

https://www.instagram.com/unbiasedscipod
1 share
https://www.instagram.com/doctor_bolu
1 share
https://www.instagram.com/myphitpharmacist
1 share

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 58%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

S2 Ep36: Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

Season 2 · Episode 36

Thursday, August 29, 2024 • Duration 16:45

Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatment in the breast cancer space.

S2 Ep35: Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

Season 2 · Episode 35

Friday, August 23, 2024 • Duration 26:42

The Alzheimer disease treatment landscape is rapidly changing, with several new FDA-approved antibody therapies that target amyloid plaque and aim to slow disease progression. While the controversial approval of aducanumab faced challenges, newer drugs like lecanemab and donanemab have shown more promising results in clinical trials, demonstrating cognitive benefits. Additionally, the pipeline includes novel therapies targeting tau protein and other mechanisms. Advancements in biomarker development, including plasma and imaging tests, are also enabling earlier diagnosis and the potential for preventive treatments before the onset of clinical symptoms.

Experts Include:
Pamela Spicer, neuroscience expert and therapy area Director, Citeline
Martin Tolar, MD, PhD, founder, president, CEO, Alzheon
Sharon Cohen, MD, FRCPC, medical director, site principal investigator, Toronto Memory Program

Pharmacy Focus – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Pharmacy Focus – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other90

LinkedIn21

Instagram11

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Other90

LinkedIn21

Instagram11